Holen Sie sich die Stockscreener-App
10.49
1.87%
-0.20
Handel nachbörslich:
10.50
0.010
+0.10%
Schlusskurs vom Vortag:
$10.69
Offen:
$10.6
24-Stunden-Volumen:
1.02M
Relative Volume:
0.57
Marktkapitalisierung:
$588.86M
Einnahmen:
$27.46M
Nettoeinkommen (Verlust:
$-46.05M
KGV:
-8.1318
EPS:
-1.29
Netto-Cashflow:
$-33.83M
1W Leistung:
+2.94%
1M Leistung:
+35.35%
6M Leistung:
+50.29%
1J Leistung:
+29.83%
1-Tages-Spanne:
$10.37
$10.66
1-Wochen-Bereich:
$10.07
$11.23
52-Wochen-Spanne:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Firmenname
Zevra Therapeutics Inc
Sektor
Branche
Telefon
(321) 939-3416
Adresse
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Vergleichen Sie ZVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
10.49 | 600.08M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-08 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-10-07 | Eingeleitet | Guggenheim | Buy |
| 2024-09-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-09-24 | Bestätigt | Maxim Group | Buy |
| 2024-04-02 | Bestätigt | Maxim Group | Buy |
| 2024-03-12 | Eingeleitet | William Blair | Outperform |
| 2023-03-17 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Zevra Therapeutics Inc Aktie (ZVRA) Neueste Nachrichten
Should you wait for a breakout in Zevra Therapeutics Inc.Quarterly Trade Review & Daily Risk Controlled Trade Plans - newser.com
Is this a good reentry point in Zevra Therapeutics Inc.Gold Moves & Growth Focused Stock Pick Reports - newser.com
Will breakout in Zevra Therapeutics Inc. lead to full recoveryEntry Point & Community Trade Idea Sharing Platform - newser.com
Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Down Following Insider Selling - MarketBeat
Using economic indicators to assess Zevra Therapeutics Inc. potentialIPO Watch & Free Fast Gain Swing Trade Alerts - newser.com
What the charts say about Zevra Therapeutics Inc. today2025 Dividend Review & Weekly Top Performers Watchlists - newser.com
What to do if you’re stuck in Zevra Therapeutics Inc.Market Trend Summary & Reliable Momentum Entry Alerts - newser.com
Insider Selling: Zevra Therapeutics (NASDAQ:ZVRA) CEO Sells 19,500 Shares of Stock - MarketBeat
Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call - 富途牛牛
Zevra Therapeutics, Inc. $ZVRA Position Cut by Janney Montgomery Scott LLC - MarketBeat
Zevra Therapeutics CEO Neil McFarlane sells $210k in shares By Investing.com - Investing.com Nigeria
Could Zevra Therapeutics’ (ZVRA) Insider Buying Hint at Greater Management Confidence in Growth Ahead? - Sahm
Zevra Therapeutics CEO Neil McFarlane sells $210k in shares - Investing.com India
Can Zevra Therapeutics Inc. (1GDA) stock sustain breakout momentumDip Buying & Stepwise Trade Signal Implementation - newser.com
How moving averages guide Zevra Therapeutics Inc. tradingJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock test record highs in 2025Trade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Chart overlay techniques for tracking Zevra Therapeutics Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
What moving averages say about Zevra Therapeutics Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Zevra Therapeutics (ZVRA): Evaluating Valuation Following Insider Buying and Sustained Revenue Growth - Yahoo
Zevra Therapeutics gains amid takeover speculation - MSN
Assessing Zevra Therapeutics (ZVRA) Valuation Following Strong Revenue Growth and Insider Buying - Sahm
Why global investors buy Zevra Therapeutics Inc. (1GDA) stock2025 Key Highlights & AI Enhanced Trading Signals - newser.com
Using RSI to spot recovery in Zevra Therapeutics Inc.Earnings Risk Report & Long-Term Investment Growth Plans - newser.com
What drives Zevra Therapeutics Inc stock priceBearish Engulfing Patterns & Breakout Portfolio Performance - earlytimes.in
What drives Zevra Therapeutics Inc 1GDA stock priceEx-Dividend Date Alerts & Affordable Market Growth - earlytimes.in
The Three-year Returns Have Been Decent for Zevra Therapeutics (NASDAQ:ZVRA) Shareholders Despite Underlying Losses Increasing - 富途牛牛
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
38,000-Share Inducement: Zevra Therapeutics Awards Options to Two New Hires, Vesting Over 4 Years - Stock Titan
Zevra Therapeutics (NASDAQ:ZVRA) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Zevra Therapeutics' Stock Soars on Strong Performance and Strategic Wins: What It Means for Investors - FinancialContent
Will Zevra Therapeutics Inc. rebound enough to break evenMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top dividend aristocrat candidateInflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock benefit from Fed rate cutsCPI Data & Community Consensus Stock Picks - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a buy for dividend portfoliosJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Visual trend scoring systems applied to Zevra Therapeutics Inc.2025 Major Catalysts & Fast Gain Stock Tips - newser.com
How to use a screener to detect Zevra Therapeutics Inc. breakoutsQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Zevra Therapeutics (NASDAQ:ZVRA) Rating Lowered to Hold at Wall Street Zen - Defense World
Will Zevra Therapeutics Inc. (1GDA) stock draw ESG focused funds2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
Can trapped investors hope for a rebound in Zevra Therapeutics Inc.Trade Volume Report & Weekly Setup with ROI Potential - newser.com
How Zevra Therapeutics Inc. (1GDA) stock trades in high volatilityJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
How Investors May Respond To Zevra Therapeutics (ZVRA) European Review of MIPLYFFA for Rare Disease Expansion - Sahm
Finanzdaten der Zevra Therapeutics Inc-Aktie (ZVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):